Literature DB >> 25087675

Varicella hospitalizations in Los Angeles during the varicella vaccination era, 2003-2011: are they preventable?

Anya Agopian1, Adriana Lopez2, Dulmini Wilson3, Vi Peralta3, Alvin Nelson El Amin3, Stephanie Bialek2.   

Abstract

Characteristics of varicella-related hospitalizations in the mature varicella vaccination era, including the proportion vaccinated and the severity of disease, are not well described. We present the vaccination status, severity and reasons for hospitalization of the hospitalized varicella cases reported to the Los Angeles County Health Department from 2003 to 2011, the period which includes the last 4 years of the mature one-dose program and the first 5 years after introduction of the routine two-dose program. A total of 158 hospitalized varicella cases were reported overall, of which 52.5% were potentially preventable and eligible for vaccination, 41.8% were not eligible for vaccination, and 5.7% were vaccinated. Most hospitalizations (72.2%) occurred among healthy persons, 54.4% occurred among persons ≥20 years of age, and 3.8% of hospitalizations resulted in death. Our data suggest that as many as half of the hospitalized varicella cases, including half of the deaths, may have been preventable given that they occurred in persons who were eligible for vaccination. More complete implementation of the routine varicella vaccination program could further reduce the disease burden of severe varicella.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Severe varicella; Varicella complications; Varicella hospitalizations; Varicella vaccination

Mesh:

Substances:

Year:  2014        PMID: 25087675      PMCID: PMC4855290          DOI: 10.1016/j.vaccine.2014.07.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.

Authors:  F Lin; J L Hadler
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

2.  Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.

Authors:  Matthew M Davis; Mitesh S Patel; Achamyeleh Gebremariam
Journal:  Pediatrics       Date:  2004-09       Impact factor: 7.124

3.  Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.

Authors:  Adriana S Lopez; John Zhang; Cedric Brown; Stephanie Bialek
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

4.  Varicella in children with cancer: impact of antiviral therapy and prophylaxis.

Authors:  S Feldman; L Lott
Journal:  Pediatrics       Date:  1987-10       Impact factor: 7.124

Review 5.  Varicella vaccine effectiveness in the US vaccination program: a review.

Authors:  Jane F Seward; Mona Marin; Marietta Vázquez
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

6.  Decrease in varicella incidence after implementation of the 2-dose recommendation for varicella vaccine in New Hampshire.

Authors:  Elizabeth R Daly; Ludmila Anderson; John Dreisig; Jodie Dionne-Odom
Journal:  Pediatr Infect Dis J       Date:  2013-09       Impact factor: 2.129

7.  Varicella disease after introduction of varicella vaccine in the United States, 1995-2000.

Authors:  Jane F Seward; Barbara M Watson; Carol L Peterson; Laurene Mascola; Jan W Pelosi; John X Zhang; Teresa J Maupin; Gary S Goldman; Laura J Tabony; Kimberly G Brodovicz; Aisha O Jumaan; Melinda Wharton
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

8.  Varicella in infants after implementation of the US varicella vaccination program.

Authors:  Sandra S Chaves; Adriana S Lopez; Tureka L Watson; Rachel Civen; Barbara Watson; Laurene Mascola; Jane F Seward
Journal:  Pediatrics       Date:  2011-11-28       Impact factor: 7.124

9.  Epidemiology of varicella hospitalizations in the United States, 1995-2005.

Authors:  Meredith A Reynolds; Barbara M Watson; Kelly K Plott-Adams; Aisha O Jumaan; Karin Galil; Teresa J Maupin; John X Zhang; Jane F Seward
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

10.  Impact of a routine two-dose varicella vaccination program on varicella epidemiology.

Authors:  Stephanie R Bialek; Dana Perella; John Zhang; Laurene Mascola; Kendra Viner; Christina Jackson; Adriana S Lopez; Barbara Watson; Rachel Civen
Journal:  Pediatrics       Date:  2013-10-07       Impact factor: 7.124

View more
  2 in total

Review 1.  Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review.

Authors:  Jessica Leung; Karen R Broder; Mona Marin
Journal:  Expert Rev Vaccines       Date:  2017-02-28       Impact factor: 5.217

2.  Effects of Shield1 on the viral replication of varicella‑zoster virus containing FKBP‑tagged ORF4 and 48.

Authors:  Shuying Li; Zhanjun Liu; Ji Li; Aihua Liu; Lihua Zhu; Kui Yu; Ke Zhang
Journal:  Mol Med Rep       Date:  2017-11-06       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.